Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
Filter by Categories
Case Report
Case Series
Editorial
Journal Review
Journal Summary
Letter to Editor
Letter to the Editor
Original Article
Review Article
Summary
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
Filter by Categories
Case Report
Case Series
Editorial
Journal Review
Journal Summary
Letter to Editor
Letter to the Editor
Original Article
Review Article
Summary
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
Filter by Categories
Case Report
Case Series
Editorial
Journal Review
Journal Summary
Letter to Editor
Letter to the Editor
Original Article
Review Article
Summary
View/Download PDF

Translate this page into:

Letter to the Editor
ARTICLE IN PRESS
doi:
10.25259/KPJ_10_2024

Sialuria due to GNE pathogenic variant masquerading as cerebral palsy

Department of Pediatric Neurology, Indira Gandhi Institute of Child Health, Bengaluru, Karnataka, India

*Corresponding author: Vykuntaraju K. Gowda, Department of Pediatric Neurology, Indira Gandhi Institute of Child Health, Bengaluru, Karnataka, India. drknvraju08@gmail.com

Licence
This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial-Share Alike 4.0 License, which allows others to remix, transform, and build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms.

How to cite this article: Gowda VK, Roy AC, Srinivasan VM. Sialuria due to GNE pathogenic variant masquerading as cerebral palsy. Karnataka Paediatr J. doi: 10.25259/KPJ_10_2024

Dear Editor,

Sialuria (OMIM#269921) is an inborn error of metabolism that leads to abnormally high free sialic acid and occurs due to mutations dominant mutations in the GNE gene.[1] A total of ten case studies have been published to date. Here, we report the 11th case from the world and the first Indian case of Sialuria, which masqueraded as cerebral palsy.

A 7-year-old male child, without any significant family and birth history presented with developmental delay and seizures from 6 months of age. The child had a global developmental delay with a predominant delay in the motor domain. He currently walks with difficulty, needs help for activities of daily living, and speaks in phrases with dysarthria. Seizures were noted at 6 months of age, with frequency of 1–2 episodes per year, requiring 2 antiseizure medications. The child also had stiffness of limbs starting from 2 years of age. On examination, weight -15.5 kg, height -101 cm, and head circumference -48 cm all are <3. Standard deviation, spasticity in all four limbs, exaggerated deep tendon reflexes, and extensor planters. Hepatosplenomegaly and coarse facies were absent. On investigations, complete hemograms, liver and kidney function tests, ammonia, lactate, blood gases, and tandem mass spectrometry were normal. Magnetic resonance imaging (MRI) brain showed mild cerebral atrophy with dilated ventricles. Exome sequencing identified a likely pathogenic missense variant c.2086G>A, p.(Val696Met) in the GNE gene. Parents did not consent to testing. Urinary total N-Acetylneuraminic acid: 1.4 (0.41 ± 0.23 mmol/g creatinine) and Free N-Actylneuraminic acid: 1.0 (0.24 + 0.14 mmol/g creatinine) was elevated.

In summary, the child has a global developmental delay, seizures, and spastic quadriparesis with no organomegaly, which prompted us to think of cerebral palsy, hereditary spastic paraparesis, and arginase deficiency. Exome sequencing gave us a clue like the case identified by Champaigne et al.[2] On reverse phenotyping and biochemical investigation, the diagnosis of sialuria was confirmed. Mutations affecting the allosteric site Arg 263 and Arg 266 and other variants like p.Asp84 His have been described.[3] The mutation in the current case does not lie in the allosteric domain and awaits explanation by further functional studies. In conclusion, any child with cerebral palsy and no significant birth history or changes on an MRI brain scan should be investigated for genetic aetiology.

Ethical approval

The Institutional Review Board has waived the ethical approval for this study.

Declaration of patient consent

The authors certify that they have obtained all appropriate patient consent.

Conflicts of interest

There are no conflicts of interest.

Use of artificial intelligence (AI)-assisted technology for manuscript preparation

The authors confirm that there was no use of artificial intelligence (AI)-assisted technology for assisting in the writing or editing of the manuscript and no images were manipulated using AI.

Financial support and sponsorship

Nil.

References

  1. , , , , , , et al. Clinical course and biochemistry of sialuria. J Inherit Metab Dis. 2001;24:328-36.
    [CrossRef] [PubMed] [Google Scholar]
  2. , , , , , , et al. New observation of sialuria prompts detection of liver tumor in previously reported patient. Mol Genet Metab. 2016;118:92-9.
    [CrossRef] [PubMed] [Google Scholar]
  3. , , , . Sialuria: Ninth patient described has a novel mutation in GNE. JIMD Rep. 2019;44:17-21.
    [CrossRef] [PubMed] [Google Scholar]

Fulltext Views
423

PDF downloads
14
View/Download PDF
Download Citations
BibTeX
RIS
Show Sections